There is emerging evidence that the commensal microbiota has a role in the pathogenesis
of multiple sclerosis (MS), a putative autoimmune disease of the CNS. Here, we compared …

Changes in gut microbiota have been associated with several diseases. Here, the
International Multiple Sclerosis Microbiome Study (iMSMS) studied the gut microbiome of …

Objectives: To evaluate the presence of antibodies to conformation-intact myelin
oligodendrocyte glycoprotein (MOG) in a subgroup of adult patients with clinically definite …

We present histological, MRI, and clinical features of an adult patient with relapsing
encephalomyelitis and antibodies against myelin oligodendrocyte glycoprotein (MOG) …

Objective Autoantibodies against myelin oligodendrocyte glycoprotein (MOG) occur in a
proportion of patients with inflammatory demyelinating diseases of the central nervous …

Epstein–Barr virus (EBV) infection precedes multiple sclerosis (MS) pathology and cross-
reactive antibodies might link EBV infection to CNS autoimmunity. As an altered anti-EBV T …

Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system
underpinned by partially understood genetic risk factors and environmental triggers and …

Multiple sclerosis (MS) involves the infiltration of autoreactive T cells into the CNS, yet we
lack a comprehensive understanding of the signaling pathways that regulate this process …

Background The oral sphingosine-1-phosphate receptor modulator fingolimod (FTY720)
was recently approved for the treatment of relapsing-remitting multiple sclerosis. To date …

We investigated a patient who developed multiple sclerosis (MS) during treatment with the
CTLA4‐blocking antibody ipilimumab for metastatic melanoma. Initially he showed …